163 related articles for article (PubMed ID: 28903171)
1. [Intraabdominal infections].
Adámková V
Klin Mikrobiol Infekc Lek; 2017 Jun; 23(2):64-75. PubMed ID: 28903171
[TBL] [Abstract][Full Text] [Related]
2. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options.
Leone S; Stefani S; Venditti M; Grossi P; Colizza S; De Gasperi A; Scaglione F; Sganga G; Esposito S;
Int J Antimicrob Agents; 2011 Sep; 38(3):271-2. PubMed ID: 21782394
[No Abstract] [Full Text] [Related]
3. Current strategies for the treatment of complicated intraabdominal infections.
Skrupky LP; Tellor BR; Mazuski JE
Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130
[TBL] [Abstract][Full Text] [Related]
4. Sixty-two-year-old woman with fever and abdominal pain: what antibiotics do I use?
McCollum DL; Rodriguez JM
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):240-3. PubMed ID: 22020061
[No Abstract] [Full Text] [Related]
5. New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance.
Syue LS; Chen YH; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2016 Apr; 47(4):250-8. PubMed ID: 27005457
[TBL] [Abstract][Full Text] [Related]
6. Eravacycline for the treatment of patients with bacterial infections.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2018 Apr; 54(4):245-254. PubMed ID: 29869646
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
8. Sparing anti-pseudomonas antibiotics in intraabdominal infections.
Papagheorghe R; Angelescu N
Chirurgia (Bucur); 2012; 107(4):488-93. PubMed ID: 23025116
[TBL] [Abstract][Full Text] [Related]
9. Eravacycline (Xerava)--an IV tetracycline for complicated intra-abdominal infections.
Med Lett Drugs Ther; 2019 Apr; 61(1570):61-63. PubMed ID: 31169809
[No Abstract] [Full Text] [Related]
10. Empiric antibiotic therapy for intraabdominal infections.
Nichols RL
Rev Infect Dis; 1983; 5 Suppl 1():S90-7. PubMed ID: 6342104
[TBL] [Abstract][Full Text] [Related]
11. Intraabdominal infections in the intensive care unit.
Friedrich AK; Cahan M
J Intensive Care Med; 2014; 29(5):247-54. PubMed ID: 23753232
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study.
Jean SS; Ko WC; Xie Y; Pawar V; Zhang D; Prajapati G; Mendoza M; Kiratisin P; Ramalheira E; Castro AP; Rosso F; Hsueh PR
Int J Antimicrob Agents; 2014 Sep; 44(3):222-8. PubMed ID: 25106073
[TBL] [Abstract][Full Text] [Related]
13. A spotlight on the treatment of intraabdominal infections.
Montravers P; Yung S; Tran-Dinh A
Expert Rev Clin Pharmacol; 2020 May; 13(5):469-472. PubMed ID: 32511038
[No Abstract] [Full Text] [Related]
14. Effectiveness and Safety of Tigecycline Compared with Other Broad-Spectrum Antimicrobials in Abdominal Solid Organ Transplant Recipients with Polymicrobial Intraabdominal Infections.
Liebenstein T; Schulz LT; Viesselmann C; Bingen E; Musuuza J; Safdar N; Rose WE
Pharmacotherapy; 2017 Feb; 37(2):151-158. PubMed ID: 27983753
[TBL] [Abstract][Full Text] [Related]
15. What every intensivist should know about the management of peritonitis in the intensive care unit.
Waele JJ
Rev Bras Ter Intensiva; 2018 Mar; 30(1):9-14. PubMed ID: 29742214
[No Abstract] [Full Text] [Related]
16. ACP Journal Club. After source control in intraabdominal infections, 4-day and longer-duration antibiotics did not differ at 30-days.
Kadri S; O'Grady NP
Ann Intern Med; 2015 Oct; 163(8):JC6. PubMed ID: 26502143
[No Abstract] [Full Text] [Related]
17. [Antibacterial therapy of severe intra-abdominal infections].
Boĭko VV; Ivanova IuV
Klin Khir; 2011 Sep; (9):43-6. PubMed ID: 22168024
[TBL] [Abstract][Full Text] [Related]
18. Source Identification and Source Control.
Oliver ZP; Perkins J
Emerg Med Clin North Am; 2017 Feb; 35(1):43-58. PubMed ID: 27908337
[TBL] [Abstract][Full Text] [Related]
19. Trial of short-course antimicrobial therapy for intraabdominal infection.
Sawyer RG; Claridge JA; Nathens AB; Rotstein OD; Duane TM; Evans HL; Cook CH; O'Neill PJ; Mazuski JE; Askari R; Wilson MA; Napolitano LM; Namias N; Miller PR; Dellinger EP; Watson CM; Coimbra R; Dent DL; Lowry SF; Cocanour CS; West MA; Banton KL; Cheadle WG; Lipsett PA; Guidry CA; Popovsky K;
N Engl J Med; 2015 May; 372(21):1996-2005. PubMed ID: 25992746
[TBL] [Abstract][Full Text] [Related]
20. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
